Hyundai Pharmaceutical Co., Ltd.Hyundai Pharmaceutical Co., Ltd.Hyundai Pharmaceutical Co., Ltd.

Hyundai Pharmaceutical Co., Ltd.

No trades
Market capitalization
‪222.68 B‬KRW
‪−574.89 M‬KRW
‪175.74 B‬KRW
‪21.46 M‬
Beta (1Y)
0.83
Employees (FY)
401
Change (1Y)
+16 +4.16%
Revenue / Employee (1Y)
‪438.24 M‬KRW
Net income / Employee (1Y)
‪−1.43 M‬KRW

About Hyundai Pharmaceutical Co., Ltd.


CEO
Sang-Joon Lee
Headquarters
Cheonan
Founded
1965
Identifiers
2
ISINKR7004310009
Hyundai Pharmaceutical Co., Ltd. engages in the manufacturing and distribution of pharmaceutical products, health food drinks, and medical equipment. Its major products include ethical drugs (ETC) and over-the-counter (OTC) drugs. The company was founded on July 16, 1965 and is headquartered in Cheonan, South Korea.

Check out other big names from the same industry as 004310.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
226490
Samsung KODEX KOSPI ETF Units
Weight
0.01%
Market value
‪41.65 K‬
USD
277630
MIRAE ASSET TIGER KOSPI ETF
Weight
0.01%
Market value
‪16.57 K‬
USD
302450
KB RISE KOSPI ETF Units
Weight
0.01%
Market value
‪14.06 K‬
USD
337120
SAMSUNG KODEX Fn Multi Factor ETF Units
Weight
0.07%
Market value
‪6.37 K‬
USD
328370
Hanwha PLUS KOSPI Total Return ETF Units
Weight
0.01%
Market value
‪5.33 K‬
USD
359210
SAMSUNG KODEX KOSPI TotalReturn ETF
Weight
0.01%
Market value
‪4.17 K‬
USD
227830
Hanwha PLUS KOSPI ETF
Weight
0.01%
Market value
624.18
USD
305050
KIM ACE KOSPI ETF
Weight
0.00%
Market value
511.08
USD

Explore more ETFs 

Frequently Asked Questions


The current price of 004310 is 8,520 KRW — it has decreased by −3.84% in the past 24 hours. Watch Hyundai Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange Hyundai Pharmaceutical Co., Ltd. stocks are traded under the ticker 004310.
004310 stock has risen by 25.48% compared to the previous week, the month change is a 136.34% rise, over the last year Hyundai Pharmaceutical Co., Ltd. has showed a 144.13% increase.
004310 reached its all-time high on Dec 23, 2020 with the price of 11,000 KRW, and its all-time low was 950 KRW and was reached on Jan 12, 2004. View more price dynamics on 004310 chart.
See other stocks reaching their highest and lowest prices.
004310 stock is 13.30% volatile and has beta coefficient of 0.83. Track Hyundai Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Hyundai Pharmaceutical Co., Ltd. there?
Today Hyundai Pharmaceutical Co., Ltd. has the market capitalization of ‪222.68 B‬, it has increased by 4.78% over the last week.
Yes, you can track Hyundai Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
004310 net income for the last quarter is ‪2.54 B‬ KRW, while the quarter before that showed ‪956.46 M‬ KRW of net income which accounts for 166.01% change. Track more Hyundai Pharmaceutical Co., Ltd. financial stats to get the full picture.
Yes, 004310 dividends are paid annually. The last dividend per share was 30.00 KRW. As of today, Dividend Yield (TTM)% is 0.35%. Tracking Hyundai Pharmaceutical Co., Ltd. dividends might help you take more informed decisions.
As of Jan 1, 2026, the company has 401 employees. See our rating of the largest employees — is Hyundai Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Hyundai Pharmaceutical Co., Ltd. EBITDA is ‪5.65 B‬ KRW, and current EBITDA margin is 2.20%. See more stats in Hyundai Pharmaceutical Co., Ltd. financial statements.
Like other stocks, 004310 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Hyundai Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Hyundai Pharmaceutical Co., Ltd. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Hyundai Pharmaceutical Co., Ltd. stock shows the strong buy signal. See more of Hyundai Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.